Academic literature on the topic '794.4 1:373.3.015 (043.2)'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic '794.4 1:373.3.015 (043.2).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "794.4 1:373.3.015 (043.2)"

1

Pranab, Ghosh, and Chakraborty Prasanta. "Reaction of 2-bromo-3-keto triterpenoids Deoxygenation and simultaneous debromination by Huang-Minion reduction condition." Journal of Indian Chemical Society Vol. 90, Apr 2013 (2013): 519–24. https://doi.org/10.5281/zenodo.5771267.

Full text
Abstract:
Department of Chemistry, University of North Bengal, Darjeeling-734 013, West Bengal, India <em>E-mail</em> : pizy12@yahoo.com&nbsp; &nbsp; &nbsp;Fax : 91-353-2699001 <em>Manuscript received 11 November 2010, revised 09 March 2012, accepted 07 June 2012</em> On heating 2&alpha;-bromo/2,2-dibromo lupanone (1/1a) and 2&alpha;-bromo/4&alpha;-bromo friedelin (2/2a) with diethylene glycol and hydrazine hydrate (Huang-Minion modified Wolff-Kishner reaction) under reflux produced lupane (3) and-friedelane (4), respectively. &nbsp;
APA, Harvard, Vancouver, ISO, and other styles
2

Ritchlin, C. T., P. Rahman, P. Helliwell, et al. "AB0538 POOLED SAFETY RESULTS FROM TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH 1 YEAR." Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 1300–1301. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1334.

Full text
Abstract:
Background:DISCOVER 1 &amp; 2, two double-blind, phase-3, psoriatic arthritis (PsA) trials of guselkumab (GUS, an IL-23 inhibitor), demonstrated significant improvement with GUS vs placebo (PBO) in signs and symptoms of PsA, with good tolerability, at week (w) 24 during the PBO-controlled period.1,2 Beyond w24, all patients (pts) switched to GUS. Continued treatment maintained efficacy through w52.3,4Objectives:To describe pooled safety results from the DISCOVER 1 &amp; 2 trials through 1-year of GUS treatment.Methods:Adults with active PsA (DISCOVER 1: ≥3 tender/swollen joints and C-Reactive
APA, Harvard, Vancouver, ISO, and other styles
3

Bauman, Glenn, Mohammed Rashid, Deanna L. Langer, et al. "A prospective provincial registry of PSMA PET CT for recurrent prostate cancer (PREP): Results for 4135 men." Journal of Clinical Oncology 43, no. 5_suppl (2025): 35. https://doi.org/10.1200/jco.2025.43.5_suppl.35.

Full text
Abstract:
35 Background: PREP was initiated in Ontario to provide access and characterize performance of PSMA PET CT among men with recurrent prostate cancer after primary definitive treatment (RP or RT). Methods: Between 03/18 and 09/22, 4135 men were accrued. Men were enrolled and imaged with 18F-DCFPyL at 1 of 6 participating sites within 1 of 6 clinical cohorts. Standardized reports delineated sites of recurrence and post PET management changes. Linkage to provincial databases allowed estimation of overall survival and utilization of salvage radiotherapy after PET. Results: Median follow-up was 1.8
APA, Harvard, Vancouver, ISO, and other styles
4

Müller, Franz, Michael Galler, Michael Zellner, et al. "Total Hip Arthroplasty for Hip Fractures: Time to Surgery With Respect to Surgical Revision, Failure, and Mortality." Geriatric Orthopaedic Surgery & Rehabilitation 10 (January 1, 2019): 215145931881816. http://dx.doi.org/10.1177/2151459318818162.

Full text
Abstract:
Introduction: There are increasing demands to perform surgery of hip fractures without delay. However, few studies have assessed the time to surgery in relation to outcome measurements. Methods: A total of 643 consecutive patients with a minimum age of 60 years underwent total hip arthroplasty (THA) for an intracapsular hip fracture. For this retrospective case series, demographic data and the outcome measurements—(1) any surgical revision, (2) implant failure, and (3) mortality—were documented from a prospective clinical database. The time from admission to surgery was also documented prospec
APA, Harvard, Vancouver, ISO, and other styles
5

Hoque, Md Ikram Ul, Andrew Gibson, and Scott Donne. "SnO2-QDs/Rgo Nanocomposites for Lithium Ion Battery Anodes." ECS Meeting Abstracts MA2022-02, no. 7 (2022): 2519. http://dx.doi.org/10.1149/ma2022-0272519mtgabs.

Full text
Abstract:
SnO2 is one of the most efficient materials for lithium ion battery (LIBs) anodes as it can theoretically provide a reversible capacity of 790 mAh/g (graphite, 372 mAh/g) for alloying reaction with lithium ion [(i) SnO 2 + 4 Li+ + 4e - = 2Li 2 O + Sn, (ii) Sn + xLi+ + xe- = LixSn (0 ≤ x ≤ 4.4)] during charge-discharge process [1]. In addition, SnO2 shows lowest operating potentials (average charge and discharge potentials: 0.3 V and 0.5 V vs. Li/Li+, respectively) in comparison with other transition metal oxides, facilitating a higher energy density when a full cell is constructed [2]. However
APA, Harvard, Vancouver, ISO, and other styles
6

Molina Collada, J., F. Sánchez-Alonso, C. Bohórquez, et al. "OP0138 RISK OF CANCER AFTER BIOLOGIC AND TARGETED SYNTHETIC DMARDS INITIATION IN PATIENTS WITH RHEUMATIC DISEASES AND A HISTORY OF PRIOR MALIGNANCY: DATA FROM THE BIOBADASER REGISTRY." Annals of the Rheumatic Diseases 81, Suppl 1 (2022): 88.2–89. http://dx.doi.org/10.1136/annrheumdis-2022-eular.5030.

Full text
Abstract:
BackgroundPatients with a history of cancer are routinely excluded from randomized controlled trials. As consequence, data on the safety of biologic disease modifying antirheumatic drugs (bDMARDS) and targeted synthetic (ts) DMARDs are limited. Although real world data from various national registries have not provided evidence of increased cancer recurrence, additional data from real-world registries may help to confirm safety of non-TNFi bDMARDs and tsDMARDs regarding cancer recurrence to guide treatment decisions.ObjectivesTo compare the risk of incident malignancy with exposure to differen
APA, Harvard, Vancouver, ISO, and other styles
7

Oh, H. J., M. K. Kim, Y. H. Fibrianto, et al. "337 EFFECTS OF CANINE SYNTHETIC OVIDUCT FLUID MEDIUM SUPPLEMENTED WITH THE VARIOUS ENERGY SUBSTRATES ON IN VITRO MATURATION OF CANINE OOCYTES." Reproduction, Fertility and Development 18, no. 2 (2006): 276. http://dx.doi.org/10.1071/rdv18n2ab337.

Full text
Abstract:
In most mammals, maturation occurs within the ovarian follicle, and preovulatory oocytes are ovulated and ready for fertilization within the oviduct. In contrast, bitch ovulate primary oocytes, over a three day period, undergo both maturation and fertilization within the oviduct. The present study was conducted to evaluate the effects of canine synthetic oviduct fluid (cSOF) supplemented with the various energy substrates on in vitro maturation of canine oocytes. Oocytes were recovered by mincing ovaries collected after ovariohysterectomy in bitches at the follicular stage. Only oocytes with m
APA, Harvard, Vancouver, ISO, and other styles
8

Spinale, F. G., M. Tomita, J. L. Zellner, J. C. Cook, F. A. Crawford, and M. R. Zile. "Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia." American Journal of Physiology-Heart and Circulatory Physiology 261, no. 2 (1991): H308—H318. http://dx.doi.org/10.1152/ajpheart.1991.261.2.h308.

Full text
Abstract:
Chronic supraventricular tachycardia (SVT) causes left ventricular (LV) dYsfunction and dilatation. Termination of SVT appears to improve symptoms of congestive heart failure. However, the structural events that occur during development and regression of SVT-induced cardiomyopathy are unknown. Accordingly, LV function (simultaneous echocardiogram-catheterization) and collagen content and distribution were measured in pigs (23-25 kg) assigned to three groups: 1) rapid atrial pacing (240 beats/min) for 3 wk (SVT, n = 10); 2) SVT for 3 wk, followed by deactivation of the pacemaker and a 4-wk reco
APA, Harvard, Vancouver, ISO, and other styles
9

Gossec, L., D. D. Gladman, E. Mcdearmon-Blondell, et al. "AB0550 EFFICACY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND A LOW OR HIGH SWOLLEN JOINT COUNT: A SUBGROUP ANALYSIS OF 2 PHASE 3 STUDIES (SELECT-PsA 1 AND SELECT-PsA 2)." Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 1308.2–1309. http://dx.doi.org/10.1136/annrheumdis-2021-eular.2127.

Full text
Abstract:
Background:Although most patients with psoriatic arthritis (PsA) enrolled in clinical trials have polyarticular arthritis, patients in clinical practice may present with oligoarthritis. Data on the efficacy of Janus kinase inhibitors in patients with PsA with low joint counts are limited.Objectives:To evaluate the efficacy of upadacitinib (UPA) in subgroups of patients with PsA with a low (baseline swollen joint count [SJC] &lt;5) or high (SJC ≥5) SJC (LSJ or HSJ).Methods:Data were pooled across the SELECT-PsA 11 (non-biologic disease-modifying antirheumatic drug [non-bDMARD] inadequate respon
APA, Harvard, Vancouver, ISO, and other styles
10

Shiota, Masakazu, Pietro Galassetti, Kayano Igawa, Doss W. Neal, and Alan D. Cherrington. "Inclusion of low amounts of fructose with an intraportal glucose load increases net hepatic glucose uptake in the presence of relative insulin deficiency in dog." American Journal of Physiology-Endocrinology and Metabolism 288, no. 6 (2005): E1160—E1167. http://dx.doi.org/10.1152/ajpendo.00391.2004.

Full text
Abstract:
The effect of small amounts of fructose on net hepatic glucose uptake (NHGU) during hyperglycemia was examined in the presence of insulinopenia in conscious 42-h fasted dogs. During the study, somatostatin (0.8 μg·kg−1·min−1) was given along with basal insulin (1.8 pmol·kg−1·min−1) and glucagon (0.5 ng·kg−1·min−1). After a control period, glucose (36.1 μmol·kg−1·min−1) was continuously given intraportally for 4 h with (2.2 μmol·kg−1·min−1) or without fructose. In the fructose group, the sinusoidal blood fructose level (nmol/ml) rose from &lt;16 to 176 ± 11. The infusion of glucose alone (the c
APA, Harvard, Vancouver, ISO, and other styles
More sources
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!